Identification of lactic acid bacteria strains modulating incretin hormone secretion and gene expression in enteroendocrine cells

Journal of Functional Foods

Volumn 23, Issue , 2016, Pages 348-358

  Panwar, Harsh ^a,b   Calderwood, Danielle ^a   Gillespie, Anna L ^a   Wylie, Alastair R ^c   Graham, Stewart F ^d   Grant, Irene R ^a   Grover, Sunita ^e   Green, Brian D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

^c AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^d Beaumont Research Institute   (United States)

^e NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

Diabetes; Enteroendocrine cells; Incretin hormones; Lactobacilli; Probiotic

Indexed keywords

EID: 84960390993     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.02.040     Document Type: Article

References (53)

1. Audy J., Mathieu O., Belvis J., Tompkins T.A. Transcriptomic response of immune signalling pathways in intestinal epithelial cells exposed to lipopolysaccharides, Gram-negative bacteria or potentially probiotic microbes. Beneficial Microbes 2012, 3(4):273-286.
2. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132(6):2131-2157.
3. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., Pike N.B., Strum J.C., Steplewski K.M., Murdock P.R., Holder J.C., Marshall F.H., Szekeres P.G., Wilson S., Ignar D.M., Foord S.M., Wise A., Dowell S.J. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry 2003, 278(13):11312-11319.
4. Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3(4):279-288.
5. Castellazzi A.M., Valsecchi C., Caimmi S., Licari A., Marseglia A., Leoni M.C., Caimmi D., Miraglia del Giudice M., Leonardi S., La Rosa M., Marseglia G.L. Probiotics and food allergy. Italian Journal of Pediatrics 2013, 39(47):1-10.
6. De Greef E., Vandenplas Y., Hauser B., Devreker T., Veereman-Wauters G. Probiotics and IBD. Acta Gastro-Enterologica Belgica 2013, 76:15-19.
7. Duan F.F., Liu J.H., March J.C. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes 2015, 64(5):1794-1803.
8. Dubernet S., Desmasures N., Gueguen M. A PCR based method for identification of lactobacilli at the genus level. FEMS Microbiology Letters 2002, 214(2):271-275.
9. Dylag K., Hubalewska-Mazgaj M., Surmiak M., Szmyd J., Brzozowski T. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Current Pharmaceutical Design 2014, 20(18):1149-1155.
10. Dziarski R., Tapping R.I., Tobias P.S. Binding of bacterial peptidoglycan to CD14. The Journal of Biological Chemistry 1998, 273(15):8680-8690.
11. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition (Burbank, Los Angeles County, Calif.) 2012, 28(5):539-543.
12. Flatt P.R., Green B.D. Nutrient regulation of pancreatic beta cell function in diabetes problems and potential solutions. Biochemical Society Transactions 2006, 34(5):774-778.
13. Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nature Reviews Gastroenterology and Hepatology 2012, 9(10):577-589.
14. Forssten S.D., Korczynska M.Z., Zwijsen R.M.L., Noordman W.H., Madetoja M., Ouwehand A.C. Changes in satiety hormone concentrations and feed intake in rats in response to lactic acid bacteria. Appetite 2013, 71:16-21.
15. Forsythe P. Probiotics and lung diseases. Chest 2011, 139(4):901-908.
16. Giahi L., Aumueller E., Elmadfa I., Haslberger A.G. Regulation of TLR4, p38 MAP kinase, IκB and miRNAs by inactivated strains of lactobacilli in human dendritic cells. Beneficial Microbes 2012, 3(2):91-98.
17. Gillespie A.L., Calderwood D., Hobson L., Green B.D. Whey proteins have beneficial effects on intestinal enteroendocrine cells stimulating cell growth and increasing the production and secretion of incretin hormones. Food Chemistry 2015, 189:120-128.
18. Green B.D., Gault V.A., O'Harte F.P.M., Flatt P.R. Development and therapeutic potential of incretin hormone analogues for type 2 diabetes. The British Journal of Diabetes & Vascular Disease 2005, 5:134-140.
19. Hafez M., Hayes K., Goldrick M., Grencis R.K., Roberts I.S. The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in epithelial cells. Infection and Immunity 2010, 78:2153-2162.
20. Hand K.V., Giblin L., Green B.D. Hormone profiling in a novel enteroendocrine cell line pGIP/neo: STC-1. Metabolism: Clinical and Experimental 2012, 61(12):1683-1686.
21. Hardy H., Harris J., Lyon E., Beal J., Foey A.D. Probiotics, prebiotics and immunomodulation of gut mucosal defences: Homeostasis and immunopathology. Nutrients 2013, 5(6):1869-1912.
22. Hijova E., Soltesova A. Effects of probiotics and prebiotics in ulcerative colitis. Bratislava Medical Journal 2013, 114(9):540-543.
23. Horvath A., Szajewska H. Probiotics, prebiotics, and dietary fiber in the management of functional gastrointestinal disorders. World Review of Nutrition and Dietetics 2013, 108:40-48.
24. Jafri L., Saleem S., Calderwood D., Gillespie A., Mirza B., Green B.D. Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion. Peptides 2016, 78:51-58. Epub ahead of print. 10.1016/j.peptides.2016.01.015.
25. Jepeal L.I., Boylan M.O., Wolfe M.M. GATA-4 upregulates glucose dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage. Molecular and Cellular Endocrinology 2008, 287(1-2):20-29.
26. Kamdar K., Nguyen V., DePaolo R.W. Toll-like receptor signaling and regulation of intestinal immunity. Virulence 2013, 4(3):207-212.
27. Katsuma S., Hatae N., Yano T., Ruike Y., Kimura M., Hirasawa A., Tsugimoto G. Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1. The Journal of Biological Chemistry 2005, 280:19507-19515.
28. Kelly D., Mulder I.E. Microbiome and immunological interactions. Nutrition Reviews 2012, 70:S18-S830.
29. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124(4):837-848.
30. Licciardi P.V., Wong S.S., Tang M.L., Karagiannis T.C. Epigenome targeting by probiotic metabolites. Gut Pathogens 2010, 2(1):24.
31. Liu Y., Fatheree N.Y., Dingle B.M., Tran D.Q., Rhoads J.M. Lactobacillus reuteri DSM 17938 changes the frequency of Foxp3+ regulatory T cells in the intestine and mesenteric lymph node in experimental necrotizing enterocolitis. PLoS ONE 2013, 8(12):e56547.
32. Macfarlane G.T., Cummings J.H. Probiotics and prebiotics: Can regulating the activities of intestinal bacteria benefit health?. British Medical Journal 1999, 318(7189):999-1003.
33. McCarthy T., Green B.D., Calderwood D., Gillespie A., Cryan J.F., Giblin L. STC-1 cells. The impact of food bioactives on health in vitro and ex vivo models 2015, 211-220. K. Verhoeckx, P. Cotter, I. Lopez-Exposito, C. Kleiveland, T. Lea (Eds.).
34. Molinaro F., Paschetta E., Cassader M., Gambino R., Musso G. Probiotics, prebiotics, energy balance, and obesity: Mechanistic insights and therapeutic implications. Gastroenterology Clinics of North America 2012, 41(4):843-854.
35. Naser S.M., Dawyndt P., Hoste B., Gevers D., Vandemeulebroecke K., Cleenwerck I., Vancanneyt M., Swings J. Identification of lactobacilli by pheS and rpoA gene sequence analyses. International Journal of Systematic and Evolutionary Microbiology 2007, 57(12):2777-2789.
36. Neumiller J.J. Incretin pharmacology: A review of the incretin effect and current incretin-based therapies. Cardiovascular & Hematological Agents in Medicinal Chemistry 2012, 10(4):276-288.
37. Oki K., Kudo Y., Watanabe K. Lactobacillus saniviri sp. nov. and Lactobacillus senioris sp. nov., isolated from human faeces. International Journal of Systematic and Evolutionary Microbiology 2012, 62:601-607.
38. Panwar H., Calderwood D., Grant I.R., Grover S., Green B.D. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential. European Journal of Nutrition 2014, 53(7):1465-1474.
39. Panwar H., Calderwood D., Grant I.R., Grover S., Green B.D. Lactobacilli possess inhibitory activity against dipeptidyl peptidase-4 (DPP-4). Annals of Microbiology 2015, 66(1):505-509.
40. Prakash S., Tomaro-Duchesneau C., Saha S., Rodes L., Kahouli I., Malhotra M. Probiotics for the prevention and treatment of allergies, with an emphasis on mode of delivery and mechanism of action. Current Pharmaceutical Design 2013, 20(6):1025-1037.
41. Rafferty E.P., Wylie A.R., Hand K.H., Elliott C.E., Grieve D.J., Green B.D. Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1 R(-/-) mice. The Journal of Biological Chemistry 2011, 392(6):539-546.
42. Ramshur E.B., Rull T.R., Wice B.M. Novel insulin/GIP co-producing cell lines provide unexpected insights into gut K-cell function in vivo. Journal of Cellular Physiology 2002, 192(3):339-350.
43. Rasouli M., Ahmad Z., Omar A.R., Allaudin Z.N. Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment. BMC Biotechnology 2011, 11(99):1-8.
44. Rogall T.J., Wolters T.F., Bottger E.C. Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. International Journal of Systematic Bacteriology 1990, 40:323-330.
45. Sanz Y., Santacruz A., Gauffin P. Gut microbiota in obesity and metabolic disorders. Proceedings of the Nutrition Society 2010, 69(3):434-441.
46. Simon M.C., Strassburger K., Nowotny B., Kolb H., Nowotny P., Burkart V., Zivehe F., Hwang J.H., Stehle P., Pacini G., Hartmann B., Holst J.J., MacKenzie C., Bindels L.B., Martinez I., Walter J., Henrich B., Schloot N.C., Roden M. Intake of Lactobacillus reuteri Improves incretin and insulin secretion in glucose tolerant humans: A proof of concept. Diabetes Care 2015, 38(10):1827-1834.
47. Speck M., Cho Y.M., Asadi A., Rubino F., Kieffer T.J. Duodenal-jejunal bypass protects GK rats from β cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. American Journal of Physiology, Endocrinology and Metabolism 2011, 300(5):E923-E932.
48. Tate M., Chong A., Robinson E., Green B.D., Grieve D.J. Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes. British Journal of Pharmacology 2015, 172(3):721-736.
49. Turner S., Pryer K.M., Miao V.P.W., Palmer J.D. Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis. Journal of Eukaryotic Microbiology 1999, 46(4):327-338.
50. Umeki U., Oue K., Mochizuki S., Shirai Y., Sakai K. Effect of Lactobacillus rhamnosus KY-3 and cellobiose as synbiotics on lipid metabolism in rats. Journal of Nutritional Science and Vitaminology 2004, 50(5):330-334.
51. Walter J., Ley R. The human gut microbiome: Ecology and recent evolutionary changes. Annual Review of Microbiology 2011, 65:411-429.
52. Standard methods for the examination of dairy products 2004, 2004. American Public Health Association, Baltimore, United States of America. H.M. Wehr, J.F. Frank (Eds.).
53. Yadav H., Lee J.H., Lloyd J., Walter P., Rane S.G. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. The Journal of Biological Chemistry 2013, 288(35):25088-25097.